Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
17.69
-0.17 (-0.95%)
At close: Oct 13, 2026, 4:00 PM EDT
17.55
-0.14 (-0.79%)
After-hours: Oct 13, 2026, 7:51 PM EDT
Beta Bionics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Beta Bionics stock has a consensus rating of "Buy" and an average price target of $24.24. The average 1-year stock price forecast is 37.03% higher than the current stock price, while the lowest is $16 (-9.55%) and the highest is $30.4 (+71.85%).
Price Target: $24.24 (+37.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Beta Bionics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 3 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 12 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Initiates $30 | Buy | Initiates | $30 | +69.59% | Oct 12, 2026 |
| Barclays | Barclays | Buy Initiates $30 | Buy | Initiates | $30 | +69.59% | Oct 6, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $23 → $28 | Buy | Reiterates | $23 → $28 | +58.28% | Sep 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $28 | Buy | Initiates | $28 | +58.28% | Sep 23, 2026 |
| Lake Street | Lake Street | Buy Reiterates $25 | Buy | Reiterates | $25 | +41.32% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
126.05M
from 100.25M
Increased by 25.74%
Revenue Next Year
182.15M
from 126.05M
Increased by 44.51%
EPS This Year
-1.84
from -1.38
EPS Next Year
-2.33
from -1.84
EPS and Forward PE are based on non-GAAP adjusted numbers.